by Paul Krzyzanowski | Sep 20, 2012
[pullquote]How will Romney’s opinion change in light of papers, which describe healthy mice being created from iPS cells?[/pullquote]As 2012 slowly creeps on we can finally see November’s Presidential Election in the United States on the horizon marking the end of a...
by Angela C. H. McDonald | Aug 30, 2012
If you tuned into the evening news on Monday night (at least here in Canada), you would have seen my PhD supervisor Janet Rossant, discussing a recent advancement in stem cell differentiation. Amy Wong, post-doctoral fellow in the Rossant lab, created a protocol for...
by Michelle Ly | Jul 31, 2012
Chances are you know someone with autism spectrum disorder, or have, at the very least, been exposed to it in the media. Films like I am Sam, Rain Main, What’s Eating Gilbert Grape and well-publicized stories such as that of Hollywood starlet Jenny McCarthy and her...
by Angela C. H. McDonald | Jun 29, 2012
Pluripotency describes the potential of a stem cell to differentiate into any cell type in the body. Embryonic stem cells derived from the early pre-implantation embryo are pluripotent as well as their engineered counterparts, iPSCs (induced pluripotent stem cells)....
by Stem Cell Network | Dec 29, 2010
Earlier this month, the Honourable Tony Clement, Minister of Industry, announced the establishment of the Centre for the Commercialization of Regenerative Medicine (CCRM) with a $15 million initial investment. The CCRM will be based in Toronto and is one of five new...
Comments